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Abstract
Fracture treatment is an old endeavour intended to promote bone healing and to also enable early loading and regain of
function in the injured limb. However, in today’s clinical routine the healing potential of the initial fracture haematoma is
still not fully recognized. The Arbeitsgemeinschaft für Osteosynthesefragen (AO) formed in Switzerland in 1956 formulated
four AO principles of fracture treatment which are still valid today. Fracture treatment strategies have continued to evolve
further, as for example the relatively new concept of minimally invasive plate osteosynthesis (MIPO). This MIPO treatment
strategy harbours the benefit of an undisturbed original fracture haematoma that supports the healing process. The
extent of the supportive effect of this haematoma for the bone healing process has not been considered in clinical
practice so far. The rising importance of osteoimmunological aspects in bone healing supports the essential role of the
initial haematoma as a source for inflammatory cells that release the cytokine pattern that directs cell recruitment towards
the injured tissue. In reviewing the potential benefits of the fracture haematoma, the early development of angiogenic
and osteogenic potentials within the haematoma are striking. Removing the haematoma during surgery could negatively
influence the fracture healing process. In an ovine open tibial fracture model the haematoma was removed 4 or 7 days
after injury and the bone that formed during the first two weeks of healing was significantly reduced in comparison with
an undisturbed control. These findings indicate that whenever possible the original haematoma formed upon injury
should be conserved during clinical fracture treatment to benefit from the inherent healing potential.
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Fracture treatment: a retrospective reflection
Fracture healing is a well-orchestrated process involving
the interplay of multiple cell types, various cytokines, che-
mokines, and growth factors which can result in reconsti-
tuted bone without any scar tissue. However, despite the
great developments in fracture management that have been
made in the last century, the healing sequence is vulnerable,
as even today the outcome in up to 10% of fractures is un-
satisfying for the patient and the clinician (Dimitriou et al.
2005; Haas 2000). The standard treatment of fractures by
coaptation and limb traction with bed rest, which resulted
in many cases in muscular atrophy, joint contractures and
poor functional outcome, began to be seriously questioned
with the introduction of intramedullary nailing of femoral
fractures by Kűntscher in Germany in the 1940s, and then
later the formation of the Arbeitsgemeinschaft fűr Osteo-
synthesefragen (AO) in Switzerland in 1956 (Heim 2001).
The four AO principles of fracture treatment that were
directed towards early return to full function were the
following: 1. Accurate anatomical reduction especially of
intra-articular fractures, 2. Atraumatic operative technique
preserving the vitality of bone and soft tissues, 3. Rigid
internal fixation, and 4. Avoidance of soft tissue damage
and so-called “fracture disease” (Müller et al. 1979). An
integral part of the AO mission has been the teaching of in-
ternal fixation techniques often using plastic bone models.
Understandably, this method of teaching focused on the
first and third AO principles, and the preservation of soft
tissues espoused by the second principle was often over-
looked in the plastic bone exercise and later in the surgical
operating room. Moreover during this early period,
the quest to achieve complete anatomical fracture re-
duction, interfragmentary compression and callus-free
primary bone union became the principle aspiration for
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the fracture surgeon. During such surgical procedures, the
fracture haematoma was simply flushed away to allow a
better view of the fracture fragments, thus allowing
absolute anatomical reduction with interfragmentary com-
pression and therefore primary fracture healing. Indeed, in
the 1980s, the importance of the fracture haematoma was
controversially discussed. One view was that the fracture
haematoma was a hindrance to union, while others con-
sidered that the fibrin network of the blood clot acted as a
scaffold for fibrocellular invasion, and hence was beneficial
to fracture repair (Sevitt 1981).
The introduction of the concept of minimally invasive
plate osteosynthesis (MIPO) around the turn of this cen-
tury was founded on the emerging body of evidence that
both the bone blood supply and the fracture haematoma
should be preserved to optimize the fracture healing
process, especially in cases of extra-articular diaphyseal
fractures (Tong and Bavonratanavech 2007; Wagner and
Frigg 2006). This approach to management of closed
diaphyseal fracture in clinical practice has been greatly
facilitated by the widespread introduction of locking
bridging plates, as well as new locked nailing technology
that respects periosteal blood perfusion. Relative fracture
stability can be achieved with a bridging locked plate fix-
ation, leading to secondary bone union with callus forma-
tion. One advantage of locked plates is that they do not
need to be accurately contoured to the surface of the
underlying bone because the construct stability is largely
due the angular stability of the locked screws, and it does
not rely on friction between the undersurface of the plate
and the bone as is the case with conventional bone plates
such as the limited contact dynamic compression plates
(Babst et al. 2012). Consequently it has been proposed
that locked plates produce less disruption of periosteal
blood flow in the underlying cortical bone, although this
has not been definitely demonstrated experimentally.
However, the effects of locked plates and conventional
bone plates on the fracture haematoma per se are likely to
be similar, and depend more upon the surgical techniques
used for fracture reduction and implant placement (Tong
and Bavonratanavech 2007). Both locking plates and the
limited contact dynamic compression plates can be ap-
plied with compression plates function (absolute stability)
or bridging plate function (relative stability), depending on
the degree of fracture comminution.
In the context of the importance of the haematoma in
fracture repair the reaming procedure should be consid-
ered as it is associated with increased bleeding. Reaming
of the medullary canal of the femur for autologous bone
graft collection using the reamer-irrigator-aspirator
creates a cavity that fills with haematoma due to the ex-
tensive disruption of the medullary arterial vasculature.
Magnetic resonance imaging studies of patients at 3
months following this procedure have demonstrated
intense vascularization of the endosteal surface of the
cortex, with new blood vessels progressing circumferen-
tially from the periphery of the haematoma, centrally
into the canal (Rankine et al. 2015). This was subse-
quently followed at 14 months or more by reformation
of normal intramedullary bone. In the case of diaphyseal
fractures of long bones, intramedullary reaming prior to
intramedullary nailing is primarily performed for mech-
anical reasons; insertion of a larger diameter nail in-
creases stability of the fracture repair construct.
However, intramedullary nailing following reaming was
shown to impair vascular perfusion acutely in approxi-
mately 70% of the tibial cortex of experimental dogs
(Klein et al. 1990). Furthermore, the immediate insertion
of an intramedullary nail following reaming apparently
tamponades the ruptured intramedullary vessels,
preventing the formation of a large intramedullary
haematoma as seen with the reamer-irrigator-aspirator
procedure (Rankine et al. 2015). As a consequence, res-
toration of intramedullary ossification following fracture
union and nail removal is considered to be less likely in
the longer term (Rankine et al. 2015).
The purpose of this review is to examine the current
knowledge about the importance of the fracture haema-
toma in bone healing. This review will be completed by
original research data on the effect of fracture haema-
toma removal during open fracture reduction. These
data support the relative importance of the fracture
haematoma in secondary bone union.
When should a haematoma be kept intact in
current clinical treatment concepts?
In the case of reconstructable intra-articular fractures,
the AO-principles of open reduction with anatomical
realignment and rigid stability will include the complete
removal of the haematoma (Fig. 1a). This treatment aims
at primary bone healing with little or no callus formation
to preserve the synovial joint mobility. If, however, the
reduction is not anatomical or the fixation allows
relative interfragmentary movements, any consecutive
bleeding will lead to a second, less competent haema-
toma with inferior biological quality. In such cases,
fracture healing is both biologically and mechanically
challenged and the risk of delayed or non-union drastic-
ally increases.
In extra-articular diaphyseal fractures the haematoma,
as well as all other soft tissue structures, can be kept in
place and must not be removed. The restoration of bone
length, and axial and torsional alignment in these cases
is more important than anatomical reduction of the
fracture (Fig. 1b). In these cases the principle of minim-
ally invasive treatment (e.g. percutaneous bridging plate)
would conserve the haematoma and thus an important
contributor to the healing process.
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Phases of bone healing: early critical role of
fracture haematoma
Each healing process starts with haematoma formation
(Fig. 2) in the inflammatory phase, simply resulting from
blood vessel disruption upon injury and fracturing of the
bone (Opal 2000). Inherently, the initial phase of the
healing process is considered to be one of the critical
determinants of the healing outcome (Kolar et al. 2010).
With the onset of inflammation, regeneration begins by
migration of mesenchymal stem cells, endothelial cells,
and immune cells towards the fractured bone region
(Kolar et al. 2010; Oe et al. 2007; Schmidt-Bleek et al.
2012a). An important feature of bone healing seems to
be the tight regulation of the inflammatory phase. The
upregulation of anti-inflammatory signalling coincides
with the upregulation of angiogenic factors in the bone
haematoma (Schmidt-Bleek et al. 2012a; Schmidt-Bleek
et al. 2015). Within the first four days after trauma, the
fracture haematoma develops an osteogenic potential
that enables bone formation in ectopic locations when
explanted and consequently secondary fracture healing
(Mizuno et al. 1990). In human fracture haematoma, an
upregulation of the osteogenic factors SPP1 (secreted
phosphoprotein 1 / osteopontin) and RunX2 (runt-re-
lated transcription factor 2) observed within the first
72 h supports the fact that bone formation is already ini-
tiated during the haematoma phase of fracture healing
(Kolar et al. 2011; Schmidt-Bleek et al. 2012a). Interest-
ingly the expression of bone morphogenetic proteins
(BMP) 2, 4, and 7 are relatively low in the initial healing
Fig. 1 In a comminuted fracture of the fibula and a medial malleolus avulsion fracture the standard of care would include an internal plate
fixation of the fibula fracture without the elimination of the fracture haematoma. The bone fragments would remain embedded in the ensuing
haematoma while the plate fixation would ensure maintenance of the correct axis and length of the healing fibula. On the other hand leaving
the haematoma in the medial malleolar fracture depicted here is not feasible. Here the fracture ends have to be repositioned through an
anatomical reduction and this includes the removal of the haematoma. This is of special importance as a joint is involved in the fracture and the
correct realignment of the bones of the joint has to be ensured
Fig. 2 The different tissues involved in bone regeneration are shown above with the two important revascularization steps during tissue
development. In the lower line the 5 consecutive phases of bone healing are depicted
Schell et al. Journal of Experimental Orthopaedics  (2017) 4:5 Page 3 of 11
period when compared with later healing phases (woven
bone formation, remodelling) (Lienau et al. 2010). BMP
2 and 7 are the growth factors that have been clinically
approved for the treatment of non-unions. There they are
administered after debridement and refreshing of the frac-
ture ends, often in combination with autologous bone
grafts, during the newly created initial pro-inflammatory
phase of bone healing. Hereby these growth factors are
being administered in a supraphysiological concentration
with a scaffold that enables a burst release during this
early healing phase. Amazingly recent studies imply that a
lower concentration would be even more effective
(reviewed in Schmidt-Bleek et al. 2016).
In addition to its osteogenic potential, fracture haema-
toma also develops an angiogenic potential (Schmidt-Bleek
et al. 2012a; Street et al. 2000) with revascularization of the
injured region being a prerequisite for the continuance of
the healing process (Schmidt-Bleek et al. 2015). Previous
studies determined two time points during bone healing to
be decisive for revascularization: An early time point
around day 7 (at the end of the inflammatory phase) and a
later time point around day 21 (beginning of the woven
bone formation) (Fig. 2) (Lienau et al. 2009). During the
early phase VEGF (vascular endothelial growth factor) is
upregulated (Lienau et al. 2009), which is in concurrence
with the high VEGF concentrations in human fracture
haematoma (Street et al. 2000). This early upregulation of
VEGF is conclusive as hypoxia induced angiogenesis is me-
diated by VEGF. Amazingly immune cells are potent pro-
ducers of VEGF (e.g. macrophages, dendritic cells). This
interaction of the inflammatory and revascularization step
during the early phase of healing has previously been
reviewed: Schmidt-Bleek et al. 2015.
The mesenchymal, endothelial and immune cells entering
the haematoma become embedded and generate the extra-
cellular matrix that evolves into granulation tissue before
the soft callus emerges. Cells and matrix are interdepend-
ent; cells organize their matrix, whereas the matrix provides
the microenvironment for transmitting signals governing
cellular functions, such as proliferation, differentiation, and
migration (Hutmacher et al. 2012). The adjacent tissues, in
particular the bone marrow, are the source for factors or
cells invading the region of the injured bone. Studies have
shown that the bone marrow composition is altered in the
vicinity of a fracture, both in terms of cell composition and
factor pattern (Kolar et al. 2011; Konnecke et al. 2014;
Schmidt-Bleek et al. 2012a). These changes are time
dependent; the tissue surrounding the fracture haematoma
matures during the early bone healing phase, supporting
the healing process in a tightly correlated and sequentially
determined course. During the first days, the haematoma
starts to organize and serves as a fibrin network for the
migration and proliferation of osteogenic and chondrogenic
progenitor cells (Brighton 1984). Cells and soluble
molecules within the haematoma initiate the cascade of
events essential for fracture healing (Bolander 1992). The
progenitor cells, originating from the periosteum, the bone
marrow, and the surrounding tissue (Yellowley 2013) react
to the signals sent by the haematoma and migrate into the
fracture area, thus initiating the soft callus phase of endo-
chondral bone healing. The transformation into a hard
callus depends on remodelling of proliferating cartilage into
hypertrophic cartilage, the revascularization of this region,
the onset of matrix mineralization and woven bone
formation. The stability of the fractured region is increased
(increased moment of inertia) to a certain degree through
hard callus formation (Bucher et al. 2016). However, the
mechanical properties of the bone have to be restored
during the last step of successful bone healing, namely the
remodeling phase. This remodelling phase can span several
months, until form and function of the bone are rebuilt
(Bucher et al. 2016).
Duplicity of cytokines
The haematoma represents the beginning of the healing
process. The conditions however are not ideal for cells
and thus only specific cells are active in this healing stage
(Street et al. 2000). Among these cells are macrophages
and T cells and these cells secrete a cytokine pattern
which in consequence orchestrates the healing (Gaber et
al. 2005; Gaber et al. 2009; Hoff et al. 2013). In conse-
quence the field of osteoimmunology becomes more
important in the understanding of bone regeneration, and
subsequently, inflammatory cytokines are considered as
possible therapeutic targets for bone regeneration
enhancement. In a recent study we showed the negative
effect of terminally differentiated CD8 positive T cells on
bone healing (Reinke et al. 2013). The negative effect of
these immune cell subset has been linked to the ratio of
TNFα (tumor necrosis factor alpha) and IFNγ (interferon
gamma), two pro-inflammatory cytokines. The implemen-
tation of inflammatory cytokines, however, proves to be
difficult when considered for therapeutical approaches
(Mountziaris et al. 2011). This is probably due to the tight
regulation of these factors during the normal bone healing
sequence. TNFα has been described to play an important
role during the early phase of healing, where its expression
is upregulated. After this point, TNFα is not necessary for
a certain period during the healing cascade and thus down
regulated before it is upregulated once again to support
bone formation during a later healing phase (Gerstenfeld
et al. 2003). An example for the critical balance of inflam-
matory cytokines during the healing process is the TNFα
concentration: the absence of TNFα delays fracture
healing, while a prolonged higher TNFα concentration
destroys bone (Karnes et al. 2015; Mountziaris et al. 2011).
Interleukin 17 (IL-17), which is the lead cytokine of T
helper 17 cells, for example, has catabolic effects (by
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enhancing osteoclasts), as well as anabolic effects (support-
ing osteoblasts) (Nam et al. 2012; Takayanagi 2007). These
opposing effects show that the expression is adapted to
resprective healing phases. In contrast, IFNγ has been
reported to hinder osteoclastogenesis (Arron and Choi
2000; Takayanagi et al. 2000) as well as osteoblastogenesis
(Cornish et al. 2003). Simultaneous stimulation/ inhibition
of both, bone degradation and bone formation, is not sup-
portive for regeneration. Each healing phase therefore needs
a tightly regulated signalling pattern to balance cytokines
present during certain healing stages.
Towards regeneration or scar formation
The synergistic interaction of bone cells and immune
cells, especially during the process of regeneration, is still
largely unknown even though some aspects have been in-
vestigated (Lorenzo et al. 2011). A balanced immune
response appears to be essential for a successful bone
healing process (Kolar et al. 2010; Schmidt-Bleek et al.
2012a; Schmidt-Bleek et al. 2012b) - and this balance, so
far, is best achieved in the haematoma ensuing upon in-
jury. The unique property of bone to regenerate is highly
dependent of these early processes during healing (Harty
et al. 2003). The provisional matrix, the fibrin clot, formed
upon clotting harbors proteases, growth factors and cyto-
kines governing cellular actions (Schaffer and Nanney
1996). The cells predominately active during this healing
stage are neutrophils, leucocytes, and macrophages which
initiate the first changes in the early matrix by activating
fibroblasts which in consequence release hyoluronate and
glycoporteins (fibronectin) into the developing extra cellu-
lar matrix (ECM) (Singer and Clark 1999). Upon healing
progression a granulation tissue develops further changing
the ECM by secretion of proteoglycans and collagens. It is
at this early stage of the healing process that the fate of
scarring (mainly repairing by creating a replacement tissue)
and regeneration (restoring form and function) seems to be
determined. This becomes apparent when fetal wound
healing (no scarring) is compared with adult wound healing
(scarring). A reduced vascularity and macrophage infiltra-
tion is observed in the fetal wounds when compared with
adult wounds. However, in case of a severe wound with
localized necrosis, the macrophage infiltration is enhanced
in fetal wound and scarring occurs (Hopkinson-Woolley et
al. 1994). This highlights the central role of the early in-
flammatory reaction in the haematoma in determining the
healing outcome as a crossroad towards regeneration or
scar formation (Harty et al. 2003).
The early haematoma determines the fracture
healing progress
The first steps of the healing process proceed during the
haematoma maturation. A certain cytokine pattern is
established that is essential in guiding the cell recruitment
towards the injury site but also in coordinating the cellular
activity of those cells (Hankenson et al. 2015). An example
for this coordination is the change from the macrophages
with a pro-inflammatory phenotype (M1 macrophages)
that are present in the initial fracture haematoma towards
macrophages with a M2 phenotype during the first 3 days
of healing (Schlundt et al. 2015; Sinder et al. 2015). This
switch could be regulated by a change in cytokines
towards interleukin 4 and 13. Previous studies have shown
that the injury activates the expression of factors import-
ant for the healing process. In the periosteum adjacent to
the fractured bone for example hypoxia induced factor 1
alpha, heme oxygenase-1 and platelet derived growth
factor are significantly upregulated (Fig. 3a) (unpublished
data). The importance of the cytokine pattern can be
deduced from the fact that 60 h after bony injury the
expression of relevant factors for inflammation and revas-
cularization as well as the cellular composition in all the
tissues concerned in bone healing (periosteum, fracture
haematoma and bone marrow) are distinctly changed
when a normal healing situation is compared with a
mechanically induced delayed healing situation (Fig. 3b)
(Schmidt-Bleek et al. 2012a; Schmidt-Bleek et al. 2012b).
A more thorough analysis of the expression of inflam-
matory, angiogenic and osteogenic factors after 4 and
7 days of bone healing in the haematoma and callus tissue
in the fracture gap shows that the pattern changes over
time and that a mechanically induced delayed healing
clearly influences these three aspects of healing
(Fig. 4). (For a detailed description of these experi-
ments please consult (Lienau et al. 2009; Lienau et al.
2010; Schmidt-Bleek et al. 2012a; Schmidt-Bleek et al.
2012b)). If the age of the haematoma is of importance
for the cytokine pattern and this cytokine pattern is
guiding the healing process, then a disturbance of the
haematoma with the removal of specific factors will
disturb bone formation in a healing situation.
Can the haematoma turn into a hindrance for
healing?
Apparently, the formation of fracture haematoma is cru-
cial for the initiation and the success of the secondary
fracture healing process. It would be expected that in
closed diaphyseal fractures managed by closed reduction,
followed by stabilization with external skeletal fixation
or splint or cast coaptation, that the contribution of the
fracture haematoma to fracture healing should be unper-
turbed. However, open reduction and internal fixation of
closed fractures will inevitably disrupt the fracture
haematoma, as would debridement and irrigation of
open fractures. Although open fracture reduction in
human trauma patients is a routine in clinical practice,
the influence on fracture haematoma disruption or
removal on subsequent fracture union has not been well
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studied. Moreover, since the surgical treatment of
fractures is often delayed for days or weeks because of
patient, local soft tissue or other factors, then the inter-
val until surgery and haematoma disruption is another
variable to be considered. Therefore, a pilot study in
sheep was performed in which the fracture haematoma
associated with a tibial osteotomy was removed after 4
or 7 days, respectively, to observe the hypothesized
negative effect on the early stages of fracture healing
(Lienau et al. 2009; Lienau et al. 2010).
A total of 19 female Merino mixed breed sheep
(2.5 years old) with a mean weight of 67.3 kg (±5.5 kg)
were randomly divided into three groups. All animal
experiments were carried out according to the policies
and principles established by the Animal Welfare Act,
the NIH Guide for Care and Use of Laboratory Animals
and the national animal welfare guidelines. The study
was approved by the local legal representative (G 0224/
01 and G 0172/04). In all 19 animals a standardized
mid-shaft transverse osteotomy of the right tibia, was
stabilized with a stable uni-lateral six pin external fixator,
as previously described (Epari et al. 2006; Schell et al.
2005). The osteotomy mimics an open fracture with soft
tissue injury and devascularisation at the fracture side.
The stable external fixation leads to uneventful bone heal-
ing within nine weeks (Epari et al. 2006). During surgery
the animals receive bolus injections (i.v.) of 0.25 mg/75 kg
body weight Fentanyl (Jannsen-Cilag GmbH, Neuss,
Germany) every 30 min. Prior to surgery the animals re-
ceived a 75 μg Fentanyl patch (Durogesic® 75 μg/h,
Jannsen-Cilag GmbH, Neuss, Germany) and were s.c.
injected with Flunixin (Finandyne®, IntervetDeutschland
GmbH, Unterschleißheim, Germany) according to their
bodywheight for at least 3 days post surgery.
A second surgical procedure was performed for the
removal of the fracture haematoma after 4 days (group
D4, n = 6 sheep) or 7 days (group D7, n = 6 sheep) with
wound-reclosure. Haematoma were removed and the
fracture ends were refreshed during the procedure which
was concluded by saline irrigation to ensure complete
removal of the original haematoma. The time points of
four and 7 days were chosen according to clinical prac-
tice when definitive osteosynthesis is usually performed.
The remaining seven sheep did not undergo a second
surgical procedure and formed the control group (Group
C). The sheep were sacrificed two weeks postoperatively.
Thus in all groups the healing progress was analysed
histologically two weeks after osteotomy. After sacrifice,
the tibiae were explanted for histological analysis and
the callus regions were sectioned into 3 mm slices in the
frontal plane. The slices were decalcified in EDTA, dehy-
drated with alcohol and xylol, embedded in paraffin and
cut into 4 μm-thick histological sections. Histological
analyses were performed on Movat Pentachrome stained
sections, which allowed a distinct and colorful contrast
between the different tissue types: fibrin is stained in
different shades of red, cartilage is stained deep green,
fibrous connective tissue is stained in light green-blue
and bony tissue is stained in yellow. Furthermore, cells,
e.g. osteoblasts, osteoclasts, inflammatory cells, can be
easily differentiated.
This study showed that an undisturbed fracture healing
can be characterized by a rapidly progressing periosteal
woven bone formation with only remnants of a well
Fig. 3 a Upon injury the cytokine expression changes in the periosteum directly adjacent to the bone injury: C = uninjured control, IB = injured bone
60 h after injury. HIF1a, HMOX1, and PDGF, three factors highly relevant for revascularization are significantly upregulated in the periosteum upon
injury. b Tissues involved in bone healing, periosteum, haematoma, and bone marrow were investigated under normal and delayed healing
conditions. The cytokine expression and also the cellular composition in all compartments was significantly altered under mechanically induced
delayed healing conditions. For detailed information please refer to: (Schmidt-Bleek et al. 2012a; Schmidt-Bleek et al. 2012b). For statistical analyses of
data, medians were calculated for each group per time point. Statistical comparisons between the groups were performed using the Mann–Whitney
U-test (SPSS 22; SPSS, Inc., Chicago, IL)
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organized fracture haematoma after two weeks of healing
(Fig. 5). On the other hand, haematoma removal after 4 or 7
days induced a significantly higher fraction of haematoma.
Histomorphometrical evaluation revealed a significantly
lower fraction of newly formed woven bone, which was
seldom found in the proximity of the fracture gap and
never in the direct proximity of the haematoma (Fig. 6).
The removal of the haematoma after 4 or 7 days of
healing sets a new inflammatory impulse (seen in the
previous paragraph in the expresseion data and cellular
composition). Since during physiological healing, after
only 24 h the anti-inflammatory signalling increases, ter-
minating the pro-inflammatory burst (Schmidt-Bleek et
al. 2012b), this new inflammatory impulse could be
equalized to a prolonged inflammation phase. A pro-
longed pro-inflammatory reaction has been shown to
delay bone healing (Kovach et al. 2015; Lienau et al.
2010; Schmidt-Bleek et al. 2012a). This indicates that a
delayed intervention in a clinical situation leading to a
secondary haematoma in the fractured region may delay
the healing process through the prolongation of the pro-
inflammatory phase. It is conceivable that haematoma
removal in elderly, multimorbid patients might eventu-
ally result in a delayed union, or even a non-union
(Gibon et al. 2016; Sattler and Rosenthal 2016). Even the
young healthy sheep that were included into the study
showed a distinct delay in the early healing. Whether
they could make up for the initial delay during a longer
healing period remains speculative but seems probable.
Clinical indications that the early inflammatory
reaction is essential for a successful healing
outcome
The conditions in an early fracture haematoma are not
favourable for cells because the pH value is lowered due to
the anaerobic energy turnover, the potassium and sodium
concentrations are high, and blood supply is disrupted so
that the environment is hypoxic (Street et al. 2000). These
Fig. 4 The expression profile of factors involved in inflammation, angiogenesis and osteogenesis change with the progression of healing, e.g.
from 4 to 7 days, in the fracture haematoma and is also dependent of the healing progression. The cytokine pattern in a normal, undisturbed
healing differs from one in a mechanically induced delayed healing. For statistical analyses of data, medians were calculated for each group per
time point. Statistical comparisons between the groups were performed using the Mann–Whitney U-test (SPSS 22; SPSS, Inc., Chicago, IL). (For a
detailed description of these experiments please consult (Lienau et al. 2009; Lienau et al. 2010; Schmidt-Bleek et al. 2012a; Schmidt-Bleek et
al. 2012b))
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conditions are well tolerated by some immune cells.
Among them the M1 macorphages which instantly
switch to an anaerobic energy supply and remain active
(Fangradt et al. 2012). Also T cells are able to stay func-
tional (Gaber et al. 2009). The ability to thrive under
these harsh conditions highlights the importance of im-
mune cells during this healing phase. Investigation of
cultured haematomas gained from the femur of
patients undergoing a total hip arthroplasty allowed the
monitoring of immune cells present during the early
stage of bone healing. These studies confirmed the
adaptation of immune cells via the expression of angio-
genic factors, chemoattractants and pro-inflammatory
molecules. In addition the restriction of the oxygen and
nutrient supply selectively enhanced the survival of
lymphocytes (Hoff et al. 2013). It is nowadays well
established that in the early phase of healing cell
mediated immune functions are essential for removing
necrotic debris, for promoting angiogenesis, for recruit-
ing cells to the site of injury, in short, to initiate repair/
regeneration. However next to the upregulation of the
inflammatory reaction the timely termination of this
reaction is also important, leading to a local increase of
induced regulatory T cells that suppress adaptive im-
mune responses within the fracture callus (Einhorn and
Gerstenfeld 2015). A functional immune system therefore
is important for bone healing. This led us to investigate
bone healing in immunologically impaired patients. Indeed,
cells within the fracture haematoma of immunologically
Fig. 5 Movat Pentachrome staining 14 days post surgery of the control group and the haematoma removal groups (D4, D7). The control group
shows the physiological healing pattern (1) while group D4 (2) and group D7 (3) are characterized by prominent haematoma remnants and a delayed
periosteal callus formation (overview top). The squares in the overview indicate locations of magnifications shown below for each group. a, c, and e
depict a comparison of the haematoma remnants in the osteotomy gap. Note the progressed organization of the haematoma remnants (HR) in the
control group (a), where connective tissue (CoT) predominates in the osteotomy gap. At the two weeks time point this connective tissue represents
the normal bone healing development and indicated the maturation of the haematoma towards the soft callus phase. In groups D4 and D7 the
haematoma is still unorganized with dominating erythrocytes and only a small amount of fibrin fibers without noticeable orientation (c, e). b, d, and f
show the progression of the periosteal callus (PC) with respect to the osteotomy gap. While the newly formed woven bone in the control group (b)
developed along the cortical bone (CtB) up to the original gap, this is neither seen in group D4 (d) nor in group D7 (f)
Fig. 6 Haematoma and woven bone fraction in the periosteal callus
area. Note the reverse ratio of haematoma and woven bone tissue
in the control group and the treated groups with a significantly
higher fraction of bone and a significantly lower fraction of
haematoma in the control group
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restricted patients showed an unproportionally strong pro-
inflammatory reaction, leading to an inadequate response to
local hypoxia and resulted in a decreased osteogenic
differentiation (Hoff et al. 2011). The recognition of the
importance of the immune cells for the bone healing
process lead to possible treatment options harnessing the
immune reaction by using immune modulatory strategies
to enhance bone healing (Mountziaris and Mikos 2008;
Mountziaris et al. 2011). A recent overview is given by Loi
et al. (Loi et al. 2016).
The orchestrating role of the fracture haematoma
The early phase of fracture healing is dominated by the
fracture haematoma. The complex microenvironment of
the haematoma is of great importance for migrating cell
populations. The maturation of the haematoma during
the fracture healing process changes this microenviron-
ment (Brighton 1984; Cruess and Dumont 1975). Starting
an inflammatory response is an energy-intensive process.
At this stage macrophages (M1) rapidly switch from a
resting state to a highly activated state, using glycolysis
and high glucose uptake to cover their energy demand
and to produce pro-inflammatory cytokines (O’Neill and
Hardie 2013). Due to the blood vessel disruption, the
region becomes hypoxic forcing active cells into an anaer-
obic energy supply with subsequent accumulation of lactat
(Komatsu and Hadjiargyrou 2004). In consequence, the
early fracture haematoma not only shows challenging
energetic conditions but also a low pH. The pH is chan-
ging from acidic through neutral to slightly alkaline during
the initial phase of healing (Brighton 1984; Cruess and
Dumont 1975). Granulocytes, which invade the fracture
haematoma upon injury, have a life span of about 12 h.
Upon apoptosis they release an oxidative burst, which
could damage cells involved in healing. In summary, the
conditions in the early haematoma are not ideal for
progenitor cells (Street et al. 2000). The haematoma
matures over the healing period and already after 24 h the
anti-inflammatory signalling increases, to end the pro-
inflammatory burst (Schmidt-Bleek et al. 2012b). With the
progressing differentiation of the haematoma, the factors
necessary for precursor cell differentiation probably come
to the fore. By the removal of haematoma tissue, essential
factors for periosteal and bone marrow cell proliferation
and differentiation and finally bone healing are severely
reduced or withdrawn. Disturbing the original haematoma
may therefore delay cell differentiation and consecutively
woven bone formation. Tachibana (Tachibana et al. 1991)
demonstrated that the capability of fracture haematoma to
induce ectopic woven bone formation depends on the age
of the haematoma. A mature haematoma is supposed to
contain more factors and cells essential for fracture heal-
ing than a fresh one. The secondary haematoma, formed
after removal of the original fracture haematoma, would
equal peripheral blood and is likely to provide a different
microenvironment compared to the original (removed)
fracture haematoma. Studies showed differences between
the fracture haematoma and the peripheral blood, espe-
cially regarding the immune cell population (Schmidt-
Bleek et al. 2009; Schmidt-Bleek et al. 2012a; Schmidt-
Bleek et al. 2012b). Therefore, the initial fracture haema-
toma and its surrounding tissues evolve and develop in
tight interplay. After removal of the fracture haematoma,
the finely adjusted composition of haematoma and adjacent
tissue is severely disturbed. The matured initial haematoma
is replaced by a new and therefore naïve haematoma, whose
composition does not fit to the healing stage of the sur-
rounding tissues and which in the beginning is quite detri-
mental to progenitor cells. Additionally to the removal of
essential cells and factors by harvesting, this evolutionary
mismatch between new haematoma and surrounding tissue
may further delay the fracture healing process.
Conclusion
In todays clinical routine the healing potential of the initial
fracture haematoma is still not fully recognized. In recent
years the awareness of the regenerative potential of the
early fracture haematoma rose which is documented in
the relatively new MIPO strategy that shows good results
in fracture treatment – a strategy that does not disturb
the haematoma more than necessary and is never remov-
ing parts of it.
Our knowledge about the rising importance of osteoim-
munological aspects of the healing process also supports
the important role of the intial haematoma as the first
influx of inflammatory cells and the ensuing cytokine
pattern initiating cell recruitment towards the injured tis-
sue are a direct result. Future treatment recommendations
should include the reference to the important regenerative
function of the initial fracture haematoma and thus the
recommendation to keep the initial haematoma whenever
possible during internal fixation of fractured bones.
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